Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,324
Closed -$350K 264
2022
Q4
$350K Sell
3,324
-687
-17% -$70.3K 0.04% 208
2022
Q3
$350K Sell
4,011
-1,797
-31% -$176K 0.05% 187
2022
Q2
$585K Sell
5,808
-4,249
-42% -$440K 0.07% 153
2022
Q1
$1.09M Sell
10,057
-30,969
-75% -$2.98M 0.12% 126
2021
Q4
$3.65M Sell
41,026
-14,402
-26% -$1.35M 0.4% 77
2021
Q3
$5.33M Buy
55,428
+469
+0.9% +$46.5K 0.67% 43
2021
Q2
$5.56M Buy
54,959
+2,257
+4% +$232K 0.71% 39
2021
Q1
$5.07M Buy
52,702
+5,068
+11% +$512K 0.73% 42
2020
Q4
$5.01M Buy
47,634
+7,981
+20% +$765K 0.77% 38
2020
Q3
$3.54M Buy
+39,653
New +$3.58M 0.59% 55

Other funds holding LDOS

Girard Partners's LDOS Position: Q1 2023 in Review

Girard Partners sold out of Leidos (LDOS) in Q1 2023, closing a stake of 3,324 shares — an estimated $350K sold.

Girard Partners first reported a position in LDOS in Q3 2020 and held it in 10 quarters. The position peaked at $5.56M in Q2 2021. 565 funds tracked by Wall St. Rank hold LDOS as of Q1 2023.

  • Girard Partners reported no remaining Leidos position as of Q1 2023 after selling out during the quarter.
  • Girard Partners sold 3,324 Leidos shares in Q1 2023, an estimated $350K.
  • Girard Partners first reported a position in Leidos in Q3 2020 and held it in 10 quarters.
  • Girard Partners's Leidos position peaked at $5.56M in Q2 2021.
  • 565 funds tracked by Wall St. Rank held Leidos as of Q1 2023.

Based on Girard Partners's 13F filing for Q1 2023, filed 12 May 2023.